Wang, Lei G. http://orcid.org/0000-0002-0664-2704
Montaño, Antonio R. http://orcid.org/0000-0003-3667-2338
Combs, Jason R.
McMahon, Nathan P.
Solanki, Allison
Gomes, Michelle M. http://orcid.org/0000-0003-4809-2664
Tao, Kai
Bisson, William H.
Szafran, Dani A. http://orcid.org/0000-0001-6408-9233
Samkoe, Kimberley S. http://orcid.org/0000-0002-8234-2308
Tichauer, Kenneth M.
Gibbs, Summer L. http://orcid.org/0000-0001-8077-1582
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA257942, R21CA257942, R21CA257942, R21CA257942, R21CA257942, R21CA257942, R21CA257942, R21CA257942)
ASPIRE Award from the Mark Foundation for Cancer Research
Article History
Received: 15 December 2021
Accepted: 27 February 2023
First Online: 30 March 2023
Change Date: 28 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41557-023-01213-1
Competing interests
: L.G.W., A.R.M. and S.L.G. are inventors on patent application PCT/US21/53806, ‘Zwitterionic cell-permeant and water-soluble rhodamine dyes for quantitative imaging applications’, submitted to the World Intellectual Property Organization and held by Oregon Health and Science University. This covers the composition and methods of use of the ORFluor compounds discussed herein. All other authors declare no competing interests.